Showing 1 to 10 of 12 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
The Chronic Myeloid Leukemia (CML) Registry of the GQR-LMC
Registre LMC  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Chronic Myeloid Leukemia |
Dr. Harold J. Olney Julie Delbos 514-890-8000 poste 25385 |
|
The Chronic Myeloid Leukemia (CML) Registry of the GQR-LMC
MP-HMR-09-001 Recruiting
|
CISSS DE LAVAL
HOPITAL DE LA CITE-DE-LA-SANTE
|
Chronic Myeloid Leukemia |
Dr. Danielle Talbot Solange Tremblay 450-668-1010 poste 23603 |
|
Registre canadien LMC
Registre LMC Recruiting
|
CISSS DE LA MONTEREGIE-CENTRE
HOPITAL CHARLES-LE MOYNE
|
Chronic Myeloid Leukemia |
Dr. Pierre Desjardins Caroline Millette 450-466-5000 poste 3276 |
|
A Phase 3, Multicenter, Randomized, Open-Label, Trial Evaluating the Efficacy and Safety of Asciminib Used in Consolidation With Imatinib v. Imatinib to Achieve Treatment-free Remission in Chronic Phase-Chronic Myelogenous Leukemia Patients
QC-TFR1-ABL001 NCT05413915 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Chronic Myeloid Leukemia |
Dr. Sarit Assouline Chadi Zakaria 514-340-8222 poste 28326 |
|
A Phase 3, Multicenter, Randomized, Open-Label, Trial Evaluating the Efficacy and Safety of Asciminib Used in Consolidation With Imatinib v. Imatinib to Achieve Treatment-free Remission in Chronic Phase-Chronic Myelogenous Leukemia Patients
QC-TFR1-ABL001 NCT05413915 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Chronic Myeloid Leukemia |
Dr. Lambert Busque Julie Trinh Lu 514-252-3400 poste 3336 |
|
Registre de la leucémie myéloïde chronique
MP-HMR-09-001 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Chronic Myeloid Leukemia |
Dr. Lambert Busque Michel-Olivier Gratton 514-252-3400 poste 2397 |
|
Registre canadien LMC
Registre LMC Recruiting
|
HOTEL-DIEU DE LEVIS
|
Chronic Myeloid Leukemia |
Dr. Danièle Marceau Pierre Bédard 418-835-7121 |
|
Registre de la leucémie myéloïde chronique
MP-HMR-09-001 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Chronic Myeloid Leukemia |
Dr. Vincent Éthier Anick Champoux 819-346-1110 poste 12811 |
|
A Phase 3, Multicenter, Randomized, Open-Label, Trial Evaluating the Efficacy and Safety of Asciminib Used in Consolidation With Imatinib v. Imatinib to Achieve Treatment-free Remission in Chronic Phase-Chronic Myelogenous Leukemia Patients
QC-TFR1-ABL001 NCT05413915 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Chronic Myeloid Leukemia |
Dr. Vincent Éthier Anick Champoux 819-346-1110 poste 12811 |
|
A Phase 3, Multicenter, Randomized, Open-Label, Trial Evaluating the Efficacy and Safety of Asciminib Used in Consolidation With Imatinib v. Imatinib to Achieve Treatment-free Remission in Chronic Phase-Chronic Myelogenous Leukemia Patients
QC-TFR1-ABL001 NCT05413915 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Chronic Myeloid Leukemia |
Dr. Robert Delage Philippe Nadeau 418-649-0252 poste 63115 |
Groupe d'étude en oncologie du Québec